Skip to content

Study Details

ASPIRIN Trial

(IRB#: IRB_00196168)

ASPIRIN: Comparative effectiveness of two aspirin doses for prevention of hypertensive disorders of pregnancy (HDP)

I AM INTERESTED

  • Female Only
  • Healthy Volunteers
  •   In Person
  • Paid

Who can participate?

 Gender: Female Only

  Age:

  Volunteers: Healthy Volunteers

   Location: In Person

Inclusion Criteria

  • 14+
  • Gestational age greater than 16 weeks
  • Not currently on Aspirin
  • at least one of the following high-risk criteria: i) any prior pregnancy complicated by a hypertensive disorder of pregnancy (preeclampsia or gestational hypertension) ii) current pregnancy complicated by chronic hypertension diagnosed before randomization (ACOG) iii) pre-gestational diabetes (on medication for diabetes prior to pregnancy, or diabetes is diagnosed prior to randomization with hemoglobin A1C of 6.5% or greater or abnormal 3-hour glucose tolerance test) iv) twin gestation (including higher order pregnancy reduced to twins prior to 14 weeks) v) chronic kidney disease vi) autoimmune disease (antiphospholipid syndrome, systemic lupus erythematous)

Exclusion Criteria

  • known allergy or hypersensitivity to aspirin
  • current or planned aspirin use in pregnancy for non-obstetrical indication (e.g., prior stroke/prior myocardial infraction),
  • Current therapeutic anticoagulation

Will I be paid for my time?

Yes

For more information contact:

Amber Sowles

amber.sowles@hsc.utah.edu

  801-585-5499

IRB#: IRB_00196168

PI: Torri Metz

Department: MATERNAL-FETAL MEDICINE DIV

Approval Date: 2026-03-17 22:12:00

Specialties: OB/Gyn, General

Last Updated: 6/8/23